US 11370832
Anti-Tau antibodies and methods of use thereof
granted A61KA61K2039/505A61P
Quick answer
US patent 11370832 (Anti-Tau antibodies and methods of use thereof) held by DENALI THERAPEUTICS INC. expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- DENALI THERAPEUTICS INC.
- Grant date
- Tue Jun 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K2039/505, A61P, A61P25/28